Antibiotic resistance: a protein that shuts the door on the drug
en-GBde-DEes-ESfr-FR

Antibiotic resistance: a protein that shuts the door on the drug


Bacteria have many strategies for defending themselves against antibiotics. Some destroy the drug, others pump it out or alter its target. They can also, more simply, prevent it from getting in. A team at the University of Geneva (UNIGE) has discovered how Pseudomonas aeruginosa, a bacterium responsible for infections that are often difficult to treat, very rapidly restricts the entry of imipenem, an antibiotic reserved for the most critical cases. Published in the journal Proceedings of the National Academy of Sciences (PNAS), these findings reveal a mechanism of antibiotic resistance and open up new avenues for eventually counteracting it.

To eliminate a bacterium, an antibiotic must first cross the protective envelope surrounding it. To enter bacterial cells, several antibiotics use specific channels known as ‘porins’. This is the case with imipenem, an antibiotic used to treat infections caused by Pseudomonas aeruginosa, a bacterium responsible for many hospital-acquired infections. Imipenem enters this bacterium through a porin called OprD.

However, this entry route can gradually become restricted. When attacked by immune cells, Pseudomonas aeruginosa is exposed to high concentrations of copper and zinc. In response, the bacterium gradually reduces its production of OprD porins. As a result, when imipenem is administered, it has increasing difficulty penetrating the cell and therefore becomes less effective. Antibiotic resistance then develops.

A two-stage defence system

Against this background, the team led by Karl Perron, Senior Lecturer in the Sections of Biology and of Pharmaceutical Sciences at the UNIGE Faculty of Science, turned its attention to a small protein, PtrA, located in the space between the two membranes of the bacterium, the periplasm. This protein, like others, is produced when Pseudomonas aeruginosa is in the presence of metals. But does it play a part in the bacterium's defence mechanism?

Combining genetic and biochemical experiments, the team discovered that the mere presence of PtrA is enough to make the bacterium more resistant to imipenem, even before the entry points – the OprD porins – gradually disappear. “We show that PtrA inserts itself into the same protein complexes as OprD, where it blocks the entrance of the channel to the antibiotic. We have named this phenomenon ‘adaptive impermeability’”, explains Verena Ducret, laboratory technician at the UNIGE Faculty of Science and first author of the study.

“Our results therefore show that there are two successive levels of control within Pseudomonas aeruginosa, both triggered by copper and zinc. First an immediate response, provided by PtrA, which blocks the entrance of the OprD porins already in place, then a more lasting response, which reduces the production of OprD”, summarises Karl Perron.

A further dimension of antibiotic resistance

“By showing that an existing OprD porin can be neutralised without being eliminated, our work suggests that part of the resistance escapes methods that measure the amount of porins or look for mutations”, continues Karl Perron. The study also raises the question of whether other pathogenic bacteria possess proteins in their envelope capable of the same immediate defence mechanism, and whether these strategies could one day be disabled to restore the full efficacy of these precious last-resort antibiotics.

"A periplasmic regulator establishes adaptive impermeability to control carbapenem entry"
Verena Ducret, Catarina Gonçalves Milho, Diego Gonzalez, and Karl Perron
Proceedings of the National Academy of Sciences (PNAS)
10.1073/pnas.2629125123
Archivos adjuntos
  • The small protein PtrA (orange) inserts into the channel of the porin OprD (blue), helping to limit the entry of the antibiotic imipenem. © UNIGE
Regions: Europe, Switzerland
Keywords: Science, Life Sciences, Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonios

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Trabajamos en estrecha colaboración con...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement